Seminar 2015 JC

43
Breeding Cannabis sativa for Medicinal and Industrial Applications Presented by Joseph R. Chidiac Department of Horticulture University of Arkansas

Transcript of Seminar 2015 JC

Page 1: Seminar 2015 JC

Breeding Cannabis sativa for Medicinal and Industrial Applications

Presented by Joseph R. ChidiacDepartment of Horticulture

University of Arkansas

Page 2: Seminar 2015 JC
Page 3: Seminar 2015 JC

Taxonomyo Kingdom: Plantaeo Subkingdom: Viridiplantaeo Infrakingdom: Streptophytao Superdivision: Embryophytao Division: Tracheophytao Subdivision: Spermatophytinao Class: Magnoliopsidao Superorder: Rosanaeo Order: Rosaleso Family: Cannabaceaeo Genus: Cannabiso Species: Sativa

Indica

Sativa

Page 4: Seminar 2015 JC
Page 5: Seminar 2015 JC

Legal History Pre-1900: The cultivation of cannabis was ubiquitous and

highly encouraged in every culture for its myriad of uses.

1906: Pure Food and Drug Act—required cannabis to be properly labeled.

1914: Harrison Narcotics Tax Act—gave the federal government authority to regulate the trade of narcotics.

1925: International Opium Convention—banned the export of Indian hemp but not American or European hemp.

1932: Uniform State Narcotic Act—encouraged states to adopt the authority to regulate illicit trade.

1937: Marihuana Tax Act—banned the possession and distribution of hemp outside of licensed use.

Page 6: Seminar 2015 JC

Current State of Affairs (2015)• Alaska• Arizona• California• Colorado• Connecticut• DC, Washington• Delaware• Hawaii• Illinois• Maine• Maryland• Massachusetts• Michigan• Minnesota• Montana• Nevada• New Hampshire• New Jersey• New Mexico• New York • Oregon• Rhode Island• Vermont• Washington

• Australia• Austria• Canada• Chile• China• Denmark• Egypt• Finland• France• Germany• Great Britain• Hungary• India• Italy• Japan• Korea• Netherlands• New Zealand• Poland• Portugal• Russia• Romania• Slovenia• Spain• Switzerland• Turkey• Thailand• Ukraine

• Israel• Canada

Page 7: Seminar 2015 JC

Economic Significance• Colorado:

– $98 million– *$40* million– $350 million (2014)

• California: – $104 million– $433 million (2014)

• USA: – $581 million– $3/$35 billion (2014)

• British Columbia: – $6 billion (2014)

Page 8: Seminar 2015 JC
Page 9: Seminar 2015 JC

Industrial Hemp77.5% cellulose

10% hemi-cellulose

6.8% lignin

2.9% pectin

0.9% wax and lipids

Page 10: Seminar 2015 JC

Modern Uses for Hemp

Page 11: Seminar 2015 JC

More Uses…Foods,Paper,

Jewelry,Biofuels,

Cosmetics,Soil remediation,

Bedding for livestock,Organic weed control,

Plastics and composites,Electrodes for supercapacitors,

Building materials and insulation,And much more…

Page 12: Seminar 2015 JC

Medicinal and Recreational Cannabis

Page 13: Seminar 2015 JC

Grow Operations

Page 14: Seminar 2015 JC

CannabinoidsCBG: Cannabigerol

CBGa: Cannabigerolic Acid

CBD: Cannabidiol

CBDa: Cannabidiolic Acid

THCa: Tetrahydrocannabinolic Acid

THCv: Tetrahydrocannabivarin

∆8/9-THC: Tetrahyrdocannabinol

CBC: Cannabichromene

CBN: Cannabinol

Trichome

Common potency: 5-25% THC, <2% CBD, Rest <1%.

85!

Page 15: Seminar 2015 JC
Page 16: Seminar 2015 JC
Page 17: Seminar 2015 JC

CBGa – Cannabigerolic acid

Properties:• Analgesic• Anti-bacterial• Anti-inflammatory• Anti-proliferative

Potential in treating:• Cancer

Studied for its role in the synthesis of other cannabinoids.

Page 18: Seminar 2015 JC

THCa – Tetrahydrocannabinolic acid

Properties:• Analgesic• Anti-emetic• Anti-inflammatory• Anti-insomnia• Anti-proliferative• Anti-spasmodic• Immune system

modulator• Neuroprotective

Potential in treating:• Nausea• Cancer• Lupus• Brain injury

Page 19: Seminar 2015 JC

THCa in Literature

Page 20: Seminar 2015 JC

THC - Tetrahydrocannabinol

Properties:• Analgesic• Anti-emetic• Anti-proliferative• Anti-oxidant• Antispasmodic• Neuroprotective• Appetite Stimulant• Euphoriant*

Potential in treating:• Cancer• Pain• Anorexia• HIV• PTSD• Crohn’s disease

Page 21: Seminar 2015 JC

THC in Literature

Page 22: Seminar 2015 JC

https://www.yahoo.com/parenting/dad-arrested-for-giving-cannabis-oil-to-daughter-108654025667.html

Page 23: Seminar 2015 JC

THCv - Tetrahydrocannabivarin

Properties:• Analgesic• Anorectic• Anti-emetic• Anti-epilectic• Anti-inflammatory• Bone stimulant• Euphoriant*

Potential in treating:• Diabetes• Obesity• Parkinson’s disease• Inflammation• Schizophrenia

Page 24: Seminar 2015 JC

THCv in Literature

Page 25: Seminar 2015 JC

http://blog.sfgate.com/smellthetruth/2015/01/16/bethenny-frankels-skinnygirl-marijuana-roll-your-own/

Page 26: Seminar 2015 JC

CBN - Cannabinol

Properties:• Analgesic• Anti-bacterial• Anti-emetic• Anti-epilectic• Anti-inflammatory• Anti-insomnia• Anti-proliferative• Appetite stimulant• Bone stimulant

Potential in treating:• Pain• Cancer• Anorexia

Page 27: Seminar 2015 JC

https://munchies.vice.com/articles/science-says-weed-makes-food-taste-and-smell-better

Page 28: Seminar 2015 JC

CBDa – Cannabidiolic acid

Properties:• Anti-bacterial• Anti-emetic• Anti-inflammatory• Anti-proliferative

Potential in treating:• Bacterial infections• Nausea• Cancer

Page 29: Seminar 2015 JC

CBD - Cannabidiol

Properties:• Analgesic• Antibacterial• Anti-diabetic• Anti-depressant• Anti-emetic• Anti-epilectic• Anti-inflammatory• Anti-insomnia• Anti-ischemic• Anti-psioratic• Anti-proliferative• Anti-psychotic• Anti-oxidant• Antispasmodic• Axiolitic• Bone stimulant• Neuroprotective• Vasorelaxant

Potential in treating:• Cancer• Epilepsy• Depression• Schizophrenia• Crohn’s disease• Alzheimer’s

Page 30: Seminar 2015 JC

CBD in Literature

Page 31: Seminar 2015 JC

http://www.medicaljane.com/2013/01/03/cbd-rich-strain-avidekel-sets-new-medicinal-standard/

Page 32: Seminar 2015 JC

CBC - Cannabichromene

Properties:• Analgesic• Anti-depressant• Anti-fungal• Axiolitic• Anti-inflammatory• Anti-proliferative• Bone stimulant• Neurogenic**

Potential in treating:• Pain• Depression• Inflammation• Alzheimer’s• Brain injury

Page 33: Seminar 2015 JC

CBC in Literature

Page 34: Seminar 2015 JC

http://www.huffingtonpost.com/2015/02/03/medical-marijuana-veterans-bill_n_6607408.html

Page 35: Seminar 2015 JC

CBG - Cannabigerol

Properties:• Analgesic• Anti-bacterial• Anti-epilectic• Anti-inflammatory• Anti-insomnia• Anti-proliferative• Bone stimulant• Neurogenic**

Potential in treating:• Glaucoma• Inflammatory Bowel Disease• Pain• Inflammation• Seizures

Page 36: Seminar 2015 JC

CBG in Literature

Page 37: Seminar 2015 JC

Targets for Breeding

Hexanoyl CoA Synthetase Olivetolic acid Cyclase GO Transferase

THCa Synthase

CBDa Synthase

CBCa Synthase

Cellulose Synthases

Glucotransferases

Cytochrome P450 enzymes

Methyltransferases Acetyltransferases

Elongase ∆6-desaturase

Gene Products

Page 38: Seminar 2015 JC

www.calgarycmmc.com

Page 39: Seminar 2015 JC

Selection ProcessSequence DNA of progeny and look for:

Presence of genes for biosynthesis enzymesNumber of duplicates in the genome for eachType of Promoter Region (PR)Type of Upstream Activating Region (UAR)

Single Nucleotide Polymorphisms (SNPs)

www.medicinalgenomics.com

Page 40: Seminar 2015 JC

Creating Profiles of Gene Expression

www.genomebiology.com

Page 41: Seminar 2015 JC

Testing the Potency of New Cultivars

Vs. Vs.

GCHPLC

UPLC

Page 42: Seminar 2015 JC

The Potential of New Cultivars“Charlotte’s Web”Named for

Charlotte Figi

0.5% THC17% CBD

Reduces child seizures dramatically

Alleviated epilepsy symptoms from Dravet syndrome Lived with 300 seizures per week before treatment

Had adverse effects from conventional treatment

Page 43: Seminar 2015 JC

¡Thank you all for your presence!

¿Are there any questions?